Adam Roose

VICE PRESIDENT, CELL & GENE COMMERCIAL STRATEGY

Adam joined Adjuvant in early 2018, and is a life sciences professional specializing in cell therapy bioprocessing and product development with experience in both academic and industry settings. He utilizes extensive background in project management, as well as operational expertise, to create the best possible solutions for platform specific challenges. Adam has hands-on experience in translating academic discoveries into viable manufacturable products and has worked with both academic and industrial partners in doing so.

Prior to joining Adjuvant, Adam spent several years at the Harvard Stem Cell Institute in the lab of Dr. Doug Melton, developing Melton’s proprietary Stem-Cell Derived Beta technology to an industrial standard. Adam was then a first-round hire at Semma Therapeutics where he ran the process development group and established the quality and supply chain management platform for the company. Adam received his BA from Bates College in History with a joint focus on Biology.